¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå
Prefilled Syringes
»óǰÄÚµå : 1543861
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 179 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,266,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,798,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀº 2030³â±îÁö 133¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 75¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀº 2023-2030³â CAGR 8.6%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 133¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ±âÁ¸Çü ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â CAGR 9.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 88¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾ÈÀü ÇÁ¸®ÇÊµå ½Ã¸°Áö ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 7.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 20¾ï ´Þ·¯, Áß±¹Àº CAGR 11.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀº 2023³â¿¡ 20¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 30¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â CAGRÀº 11.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 5.6%¿Í 6.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 6.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÇÁ¸®ÇÊµå ½Ã¸°Áö: ¾à¹°Àü´ÞÀÇ ¾ÈÀü¼º°ú ÆíÀǼº Çâ»ó

ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â 1ȸºÐ¾¿ Æ÷ÀåµÈ ÁÖ»ç±â·Î, ƯÁ¤ ¾àǰÀ̳ª ¹é½ÅÀÌ ¹Ì¸® ä¿öÁ® ÀÖÀ¸¸ç, ¹Ù·Î »ç¿ëÇÒ ¼ö ÀÖ´Â ÁÖ»ç±âÀÔ´Ï´Ù. ÀÌ ÁÖ»ç±â´Â ÁÖ»çÁ¦ Åõ¿©¸¦ ´Ü¼øÈ­Çϰí Á¤È®ÇÑ Åõ¿©¸¦ º¸ÀåÇÏ¸ç ¿À¿° ¹× Åõ¿© ¿À·ùÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¼³°èµÇ¾ú½À´Ï´Ù. ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â ¹é½Å, Ç×ÀÀ°íÁ¦, »ý¹°ÇÐÀû Á¦Á¦ µî Á¤È®ÇÑ Åõ¾à°ú ¹«±Õ¼ºÀÌ Áß¿äÇÑ ´Ù¾çÇÑ Ä¡·á ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¹Ì¸® ä¿öÁø ÁÖ»ç±âÀÇ ÁÖ¿ä ÀåÁ¡Àº ÀÇ·áÁøÀÌ ¹ÙÀ̾˿¡¼­ ¾à¹°À» ¼öµ¿À¸·Î ÃßÃâÇÒ Çʿ䰡 ¾ø±â ¶§¹®¿¡ ½Ã°£À» Àý¾àÇÏ°í ½Ç¼ö °¡´É¼ºÀ» ÁÙÀÏ ¼ö ÀÖ´Ù´Â Æí¸®ÇÔÀÔ´Ï´Ù. ¶ÇÇÑ ¹Ì¸® ä¿öÁø ÁÖ»ç±â´Â ¹Ù´Ã¿¡ Âñ¸± À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ°í ¿À¿° °¡´É¼ºÀ» ÁÙÀÓÀ¸·Î½á ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ãŵ´Ï´Ù. µû¶ó¼­ »ç¿ë ÆíÀǼº°ú ¾ÈÀü¼ºÀÌ ÃÖ¿ì¼±ÀÎ ÀÓ»ó ÇöÀå°ú ÀçÅà ġ·á ȯ°æ ¸ðµÎ¿¡¼­ ÇÁ¸®ÇÊµå ½Ã¸°Áö°¡ ¼±Åõǰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô ÇÁ¸®ÇÊµå ½Ã¸°Áö¸¦ °³¼±Çϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ¹Ì¸® ä¿öÁø ÁÖ»ç±âÀÇ µðÀÚÀÎ, ±â´É ¹× ¾ÈÀü¼ºÀ» Å©°Ô Çâ»ó ½ÃÄ×½À´Ï´Ù. Àç·á °úÇÐÀÇ Çõ½ÅÀº ÁÖ»ç±âÀÇ ³»±¸¼º°ú ÆÄ¼Õ ÀúÇ×À» Çâ»ó½ÃŰ°í ÆÄ¼Õ À§ÇèÀ» ÁÙÀÌ°í ¾à¹°ÀÇ ¹«°á¼ºÀ» º¸ÀåÇÏ´Â °í±Þ Æú¸®¸Ó ¹× ´ëü À¯¸®ÀÇ °³¹ß·Î À̾îÁ³½À´Ï´Ù. Á¦Á¶ °øÁ¤ÀÇ ¹ßÀüÀº ÁÖ»ç±â ÃæÀüÀÇ Á¤È®¼º°ú Àϰü¼ºÀ» Çâ»ó½ÃÄÑ Á¤È®ÇÑ Åõ¿©¸¦ º¸ÀåÇÏ°í ¹èÄ¡ °£ ÆíÂ÷¸¦ ÁÙ¿´½À´Ï´Ù. ¹Ù´Ã º¸È£´ë ¹× ÀÚµ¿ ºñȰ¼ºÈ­ ¸ÞÄ¿´ÏÁò°ú °°Àº ¾ÈÀü ±â´ÉÀÇ ÅëÇÕÀ¸·Î »çÀü ÃæÀüµÈ ÁÖ»ç±âÀÇ ¾ÈÀü¼ºÀÌ Çâ»óµÇ¾î ¹Ù´Ã¿¡ Âñ¸®´Â ºÎ»óÀÇ À§ÇèÀ» ÁÙÀ̰í Àç»ç¿ëÀ» ¹æÁöÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ µà¾ó è¹ö ÇÁ¸®ÇÊµå ½Ã¸°Áö °³¹ß·Î »ç¿ë½Ã À籸¼ºÇØ¾ß ÇÏ´Â µ¿°á°ÇÁ¶ ¾à¹°À» Àü´ÞÇÒ ¼ö ÀÖ°Ô µÇ¾î ÇÁ¸®ÇÊµå ½Ã¸°Áö·Î Àü´ÞÇÒ ¼ö ÀÖ´Â ¾à¹°ÀÇ ÆøÀÌ ³Ð¾îÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú °³¼±À¸·Î ÇÁ¸®ÇÊµå ½Ã¸°ÁöÀÇ ¿ëµµ¿Í ÀåÁ¡ÀÌ È®´ëµÇ¾î ¾à¹°Àü´ÞÀ» À§ÇÑ º¸´Ù ´Ù¾çÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼±ÅÃÀÌ µÇ¾ú½À´Ï´Ù.

ÇÁ¸®ÇÊµå ½Ã¸°ÁöÀÇ ÁÖ¿ä ¿ëµµ¿Í ÀåÁ¡Àº ¹«¾ùÀΰ¡?

ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â ´Ù¾çÇÑ ÀÇ·á ¿ëµµ¿¡ »ç¿ëµÇ¸ç ¾à¹° Åõ¿© ¹× ȯÀÚ Ä¡·á¸¦ °³¼±ÇÏ´Â ¸¹Àº ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ¹é½Å Á¢Á¾¿¡¼­ ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â Á¤È®ÇÑ Åõ¿©¸¦ º¸ÀåÇÏ°í ¿À¿°ÀÇ À§ÇèÀ» ÁÙ¿© ´ë±Ô¸ð ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ¸¸¼ºÁúȯ °ü¸®¿¡¼­ ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â Àν¶¸°, Ç×ÀÀ°íÁ¦, »ý¹°ÇÐÀû Á¦Á¦ µî Á¤È®ÇÑ Åõ¾à°ú »ç¿ë ÆíÀǼºÀÌ È¯ÀÚÀÇ ¼øÀÀµµ¿Í °á°ú¿¡ Áß¿äÇÑ ¾à¹°À» Åõ¿©ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÀ±ÞÀÇ·á ºÐ¾ß¿¡¼­ ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â ¾Æ³ªÇʶô½Ã½º¿ë ¿¡Çdz×ÇÁ¸°°ú °°ÀÌ »ý¸íÀ» À§ÇùÇÏ´Â ¾à¹°À» ½Å¼ÓÇÏ°í ¾ÈÁ¤ÀûÀ¸·Î Åõ¿©ÇÒ ¼ö ÀÖ´Â ¼ö´ÜÀ» Á¦°øÇÕ´Ï´Ù. ÇÁ¸®ÇÊµå ½Ã¸°ÁöÀÇ ÁÖ¿ä ÀåÁ¡Àº ¾ÈÀü¼º Çâ»ó, ÆíÀǼº Çâ»ó, Á¤È®ÇÑ Åõ¾à, ³¶ºñ °¨¼Ò µîÀ̸ç, ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â Åõ¾à °úÁ¤À» °£¼ÒÈ­Çϰí ÀϰüµÈ Åõ¾àÀ» º¸ÀåÇÔÀ¸·Î½á ´Ù¾çÇÑ Ä¡·á ºÐ¾ß¿¡¼­ ´õ ³ªÀº ȯÀÚ Ä¡·á¿Í °á°ú¿¡ ±â¿©ÇÕ´Ï´Ù.

ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Á¤È®ÇÏ°í ¹«±ÕÀûÀÎ Àü´Þ ¹æ¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÓ»ó ÇöÀå¿¡¼­ ÇÁ¸®Çʵå ÁÖ»ç±â äÅÃÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÁ¸®ÇÊµå ½Ã¸°ÁöÀÇ ¾ÈÀü¼º, ±â´É¼º, ´Ù¾çÇÑ ¾à¹°°úÀÇ È£È¯¼ºÀ» Çâ»ó½ÃŰ´Â ±â¼ú ¹ßÀüµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´, ½ÉÇ÷°ü Áúȯ µî Á¤±âÀûÀÎ Áֻ簡 ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÇÁ¸®ÇÊµå ½Ã¸°Áö ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀçÅÃÀÇ·áÀÇ È®´ë·Î ÀÎÇØ ÀÚ°¡ Åõ¾à¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁø °Íµµ »ç¿ëÀÚ Ä£È­ÀûÀÎ ÇÁ¸®Çʵå ÁÖ»ç±â äÅà Ȯ´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á °ü·Ã °¨¿°(HAI) °¨¼Ò¿Í ȯÀÚ ¾ÈÀü Çâ»ó¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÁÖ»ç±â µðÀÚÀÎ ¹× ¼ÒÀçÀÇ Áö¼ÓÀûÀÎ Çõ½Å°ú ÇÔ²² ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 12»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Prefilled Syringes Market to Reach US$13.3 Billion by 2030

The global market for Prefilled Syringes estimated at US$7.5 Billion in the year 2023, is expected to reach US$13.3 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Conventional Prefilled Syringes, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$8.8 Billion by the end of the analysis period. Growth in the Safety Prefilled Syringes segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 11.6% CAGR

The Prefilled Syringes market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.0 Billion by the year 2030 trailing a CAGR of 11.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.6% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Prefilled Syringes Market - Key Trends and Drivers Summarized

Prefilled Syringes: Enhancing Safety and Convenience in Drug Delivery

Prefilled syringes are single-dose, pre-packaged syringes that are filled with a specific medication or vaccine, ready for immediate use. These syringes are designed to simplify the administration of injectable drugs, ensuring accurate dosing and reducing the risk of contamination or dosing errors. Prefilled syringes are widely used in various therapeutic areas, including vaccines, anticoagulants, and biologics, where precise dosing and sterility are critical. The primary advantage of prefilled syringes is their convenience, as they eliminate the need for healthcare providers to manually draw medication from a vial, thus saving time and reducing the potential for errors. Additionally, prefilled syringes enhance patient safety by minimizing the risk of needle stick injuries and reducing the potential for contamination. This makes them a preferred choice in both clinical settings and home care environments, where ease of use and safety are paramount.

How Are Technological Advancements Enhancing Prefilled Syringes?

Technological advancements have significantly improved the design, functionality, and safety of prefilled syringes. Innovations in materials science have led to the development of advanced polymers and glass alternatives that enhance the durability and break resistance of syringes, reducing the risk of breakage and ensuring the integrity of the medication. Advances in manufacturing processes have improved the precision and consistency of syringe filling, ensuring accurate dosing and reducing variability between batches. The integration of safety features, such as needle guards and auto-disable mechanisms, has enhanced the safety of prefilled syringes, reducing the risk of needle stick injuries and preventing reuse. Additionally, the development of dual-chamber prefilled syringes has enabled the delivery of lyophilized drugs that require reconstitution at the point of use, expanding the range of medications that can be delivered via prefilled syringes. These technological improvements have expanded the applications and benefits of prefilled syringes, making them a more versatile and reliable option for drug delivery.

What Are the Key Applications and Benefits of Prefilled Syringes?

Prefilled syringes are used in a wide range of medical applications, offering numerous benefits that enhance drug administration and patient care. In vaccine administration, prefilled syringes ensure accurate dosing and reduce the risk of contamination, making them ideal for large-scale immunization programs. In chronic disease management, prefilled syringes are used to deliver medications such as insulin, anticoagulants, and biologics, where precise dosing and ease of use are critical for patient adherence and outcomes. In emergency medicine, prefilled syringes provide a rapid and reliable means of delivering life-saving medications, such as epinephrine for anaphylaxis, where time is of the essence. The primary benefits of prefilled syringes include improved safety, enhanced convenience, accurate dosing, and reduced waste, making them a preferred choice for both healthcare providers and patients. By simplifying the administration process and ensuring consistent dosing, prefilled syringes contribute to better patient care and outcomes across various therapeutic areas.

What Factors Are Driving the Growth in the Prefilled Syringes Market?

The growth in the prefilled syringes market is driven by several factors. The increasing demand for biologics and vaccines, which require precise and sterile delivery methods, is a significant driver, boosting the adoption of prefilled syringes in clinical settings. Technological advancements that enhance the safety, functionality, and compatibility of prefilled syringes with a wide range of medications are also propelling market growth. The rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, which require regular injections, is further boosting the demand for prefilled syringes. Additionally, the growing preference for self-administration of medications, driven by the expansion of home healthcare, is contributing to the increased adoption of user-friendly prefilled syringes. The emphasis on reducing healthcare-associated infections (HAIs) and improving patient safety is further supporting the market growth. These factors, coupled with the continuous innovation in syringe design and materials, are driving the sustained growth of the prefilled syringes market.

Select Competitors (Total 12 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â